Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jan. 30, 2021	Feb. 01, 2020	Feb. 02, 2019
OPERATING ACTIVITIES
Net income	$ (47,483,000)	$ 35,897,000	$ 30,461,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	14,681,000	15,485,000	16,463,000
Provision For Doubtful Accounts	306,000	524,000	470,000
Purchase premium and premium amortization	(691,000)	(694,000)	576,000
Gain on sale of asset	(2,298,000)	0	0
Share Based Compensation	4,092,000	4,669,000	4,939,000
Deferred income taxes	3,030,000	2,120,000	1,285,000
Loss on disposal of property and equipment	461,000	837,000	1,089,000
Impairment	(13,702,000)	(470,000)	(1,548,000)
Changes in operating assets and liabilities which provided (used) cash:
Accounts receivable	(26,935,000)	1,525,000	(579,000)
Merchandise inventories	31,242,000	4,220,000	1,950,000
Prepaid and other assets	(1,596,000)	5,072,000	10,384,000
Operating lease right-of-use asstes and liabilities	(2,611,000)	(9,803,000)	0
Accrued income taxes	335,000	1,703,000	(680,000)
Accounts payable, accrued expenses and other liabilities	(16,945,000)	(8,629,000)	(7,662,000)
Net cash provided by operating activities	(30,710,000)	53,396,000	60,244,000
INVESTING ACTIVITIES
Capital expenditures	(13,956,000)	(8,306,000)	(4,354,000)
Purchase of short-term investments	(74,041,000)	(218,345,000)	(157,515,000)
Sales of short-term investments	149,298,000	205,375,000	91,023,000
Purchase of Other Assets	0	(1,353,000)	(298,000)
Sales Of Other Assets	(3,205,000)	4,000	(7,000)
Net cash used in investing activities	64,506,000	(22,633,000)	(71,137,000)
FINANCING ACTIVITIES
Dividends paid	(7,912,000)	(32,592,000)	(32,577,000)
Repurchase of common stock	(19,654,000)	(9,605,000)	(13,344,000)
Proceeds from lines of credit	34,000,000	0	0
Payments to lines of credit	(34,000,000)	0	0
Proceeds from employee stock purchase plan	391,000	626,000	570,000
Proceeds From Stock Options Exercised	0	0	189,000
Net cash provided used in financing activities	(27,175,000)	(41,571,000)	(45,162,000)
Net increase in cash and cash equivalents	6,621,000	(10,808,000)	(56,055,000)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period	14,401,000	25,209,000
Cash, Cash Equivalents and Restricted Cash at End of Period	21,022,000	14,401,000	25,209,000
Change in Accrued PPE	343,000	2,828,000	326,000
Change in Accrued Treasury Stock	$ 0	$ 818,000	$ 0